Fed. Circ. Judge Asks What's The Rush In Eylea Biosimilar Case
By Nadia Dreid · January 14, 2025, 9:34 PM EST
Counsel for Amgen and a Federal Circuit judge got into a back-and-forth Tuesday concerning the pace of an appeal over a denied injunction on Regeneron's biosimilar of Eylea, with the judge...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login